HF
HBIO icon

HRT Financial’s Harvard Bioscience HBIO Stock Holding History

HRT Financial’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,146
Closed -$18K – 3182
2025
Q2 		$18K Buy
+4,146
New +$17.3K ﹤0.01% 2408
2021
Q3 		– Sell
-1,821
Closed -$151K – 3460
2021
Q2 		$151K Buy
+1,821
New +$129K ﹤0.01% 2481
2020
Q3 		– Sell
-2,810
Closed -$87K – 2077
2020
Q2 		$87K Buy
+2,810
New +$75.7K ﹤0.01% 1268

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HRT Financial's HBIO Position: Q3 2025 in Review

HRT Financial sold out of Harvard Bioscience (HBIO) in Q3 2025, closing a stake of 4,146 shares — an estimated $18K sold.

HRT Financial first reported a position in HBIO in Q2 2020 and held it in 3 quarters. The position peaked at $151K in Q2 2021. 59 funds tracked by Wall St. Rank hold HBIO as of Q3 2025.

  • HRT Financial reported no remaining Harvard Bioscience position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 4,146 Harvard Bioscience shares in Q3 2025, an estimated $18K.
  • HRT Financial first reported a position in Harvard Bioscience in Q2 2020 and held it in 3 quarters.
  • HRT Financial's Harvard Bioscience position peaked at $151K in Q2 2021.
  • 59 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.